Tuberculosis among people with HIV infection in the United Kingdom: opportunities for prevention?
Authors:
- Alison D GrantAGAlison D Grant
- Loveleen BansiLBLoveleen Bansi
- Jonathan AinsworthJAJonathan Ainsworth
- Jane AndersonJAJane Anderson
- Valerie DelpechVDValerie Delpech
- Philippa EasterbrookPEPhilippa Easterbrook
- Martin FisherMFMartin Fisher
- Brian GazzardBGBrian Gazzard
- Richard GilsonRGRichard Gilson
- Mark GompelsMGMark Gompels
- Teresa HillTHTeresa Hill
- Margaret JohnsonMJMargaret Johnson
- 27 November 2009
- journal article
- research article
- Published by Wolters Kluwer Health in AIDS
- Vol. 23 (18) , 2507-2515
Abstract
To investigate the incidence of, and risk factors for, tuberculosis among HIV clinic attendees in the United Kingdom. Observational cohort study of 27 868 individuals in the United Kingdom Collaborative HIV Cohort collaboration, 1996–2005. Among individuals not taking combination antiretroviral therapy (cART), tuberculosis incidence was considerably higher among individuals of black African vs. white or other ethnicities {incidence rates 9.9 [95% confidence intervals (CIs) 7.2, 12.6], 2.5 [95% CI 1.8, 3.0] and 4.4 [95% CI 2.7, 6.0] episodes per 1000 person-years, respectively}. Tuberculosis incidence decreased with time after starting cART; among black Africans, incidence was consistently higher and remained substantial (5.3 per 1000 person-years) at 24 months and longer after starting cART. The strongest independent risk factors for tuberculosis after cART start were most recent CD4 cell count: adjusted rate ratios (aRR) 10.65 (95% CI 6.11, 18.57), 3.40 (95% CI 2.05, 5.65), 1.77 (95% CI 1.06, 2.96) and 1.84 (95% CI 1.09, 3.12) for individuals with CD4 cell counts less than 50, 50–199, 200–349 and 350–499 cells/μl, respectively, compared with at least 500 cells/μl; and black African vs. white ethnicity [aRR 2.93 (95% CI 1.89, 4.54)]. HIV risk group, shorter time on cART, later calendar period and unsuppressed viral load were also independently associated with incident tuberculosis. Tuberculosis incidence among people attending UK HIV clinics is substantial, particularly among those with non-white ethnicity and low CD4 cell counts, even after starting cART. Earlier HIV diagnosis is needed in order to implement interventions to prevent tuberculosis; tuberculosis preventive therapy should be considered in addition to cART.Keywords
This publication has 15 references indexed in Scilit:
- Prevalence, incidence and mortality associated with tuberculosis in HIV-infected patients initiating antiretroviral therapy in rural UgandaAIDS, 2007
- Tuberculosis in London: a decade and a half of no decline in tuberculosis epidemiology and controlThorax, 2007
- Antiretroviral therapy at a district hospital in Ethiopia prevents death and tuberculosis in a cohort of HIV patientsAIDS Research and Therapy, 2006
- Incidence of Tuberculosis among HIV-Infected Patients Receiving Highly Active Antiretroviral Therapy in Europe and North AmericaClinical Infectious Diseases, 2005
- Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohortAIDS, 2005
- Effect of Routine Isoniazid Preventive Therapy on Tuberculosis Incidence Among HIV-Infected Men in South AfricaJAMA, 2005
- The creation of a large UK‐based multicentre cohort of HIV‐infected individuals: The UK Collaborative HIV Cohort (UK CHIC) StudyHIV Medicine, 2004
- Reduced Risk of Tuberculosis among Brazilian Patients with Advanced Human Immunodeficiency Virus Infection Treated with Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2002
- Impact of combination antiretroviral therapy on the risk of tuberculosis among persons with HIV infectionAIDS, 2000
- The mortality and pathology of HIV infection in a West African cityAIDS, 1993